50-year Wall Street Veteran Names Top Stock of 2026

Dear Reader,

The legendary quant who built one of Wall Street's most popular buying indicators just announced the #1 stock to buy for 2026.

And for a limited time, he's sharing this new recommendation live on-camera, completely free of charge.

He spent 50 years working alongside legendary investors like George Soros, Michael Steinhardt, Steve Cohen, and Paul Tudor Jones.

His work is coded into every Bloomberg terminal on Wall Street, and is still used by hundreds of banks, brokerages, and hedge funds to this day.

So why is he giving away his #1 buy recommendation for FREE?

It's all comes back to a shocking new market prediction for 2026.

This same legend - who accurately predicted the 2020 covid crash, the 2022 bear market, and the 2023 bank run - is now calling for an abrupt, surprising shift in the U.S. stock market.

The last time this happened, average investors lost over a fifth of their portfolio in just a matter of months.

So I got him to agree to an exclusive sit-down interview, where I got the whole story.

You'll get his #1 buy recommendation for 2026 when you click here.

To pick these recommendations, he consulted the same system that he used when CNBC's Jim Cramer said he'd never bet against him.

So I urge you to take advantage before it's too late.

Go here now to see the names and tickers while you can.

Regards,

Kelly Brown
Host, Chaikin Analytics

Notable Newcomers: These 2025 IPOs Dominated the Year

By Leo Miller. Date Posted: 1/5/2026.

Key Points

While hundreds of companies went public in 2025, three key names delivered especially impressive performances.
KRMN, CRCL, and HNGE delivered returns between 40% and more than 200%.
Analysts continue to see upside in these stocks, but to varying degrees.

In 2025, more than 200 companies completed initial public offerings (IPOs) on U.S. exchanges. Fewer than a quarter of those stocks outperformed the S&P 500's 18% return (with dividends reinvested).

Here are three 2025 IPOs that stood out — they drew significant investor attention and handily beat the market. Implied upside and downside data are as of the Jan. 2 close.

KRMN Delivers More Than Triple-Bagger Performance in 2025

What Palantir Did for Data, This Company Is Doing for Human Intelligence. (Ad)

Just like Microsoft and Adobe rode the software wave in Web 1.0, RAD Intel is riding the AI software wave in 2025. Their product helps brands instantly find the right audience and message using AI – solving the #1 waste in marketing: misfired ad spend.

Already trusted by a who's-who of Fortune 1000 brands and leading global agencies – with recurring seven-figure partnerships in place. With a Nasdaq ticker reserved, $RADI, it's early – but very real.

$0.85 Won't Last – Secure Your Shares Now.

First up is defense company Karman (NYSE: KRMN). The stock priced its IPO on Feb. 13, 2025, at $22 per share and finished the year just above $73, delivering a return of more than 230%. Karman's revenue growth accelerated each quarter in 2025; its 42% growth in the most recent quarter was double the 21% rate in Q1.

The company supplies mission-critical components to nearly every prime defense contractor in the U.S. space and defense market. These primes rely on Karman's technology to support initiatives in high-growth areas such as hypersonic missiles.

Karman's proprietary products give it meaningful pricing power. An impressive gross margin of 41% last quarter — among the top five for mid-cap and larger U.S. aerospace and defense stocks — underscores that strength.

Looking ahead, the consensus price target on Karman is $80.43, implying roughly 5% upside. While modest, that suggests analysts still see further appreciation in a stock that has already run up substantially.

Stablecoin Stock CRCL Rises 150% in Seven Months

Circle Internet Group (NYSE: CRCL) went public on June 5, 2025, at $31. It closed the year just above $79, gaining over 150%. Circle issues a stablecoin — a type of cryptocurrency pegged to a stable asset, typically the U.S. dollar.

Stablecoins deliver blockchain benefits without the volatility common to many cryptocurrencies, enabling faster, lower-cost payments compared with traditional methods.

Most of Circle's 2025 gain occurred on its first trading day, when shares closed above $83 (a 168% increase). The market appeared to view the IPO as significantly undervaluing Circle's stablecoin opportunity. In the most recent quarter, total revenue rose 66% and the circulation of the company's USD Coin expanded 108% to $73.7 billion.

Analysts generally remain bullish. The consensus price target is $141.18 (about 69% upside). However, price targets revised after the company's Nov. 12 earnings report lower the average to roughly $101 (about 21% upside) and range widely from $60 to $190.

Analysts Eye +40% Upside in HNGE After Strong 2025

Hinge Health (NYSE: HNGE) also posted an impressive 2025. The stock priced its IPO on May 22 at $32 and closed 2025 near $46.50, up about 45%.

Hinge aims to reduce healthcare costs associated with physical therapy through products such as its smartphone app and an FDA-cleared wearable device. These offerings deliver customized at-home physical therapy exercises, helping patients spend less time and money on in-person therapy.

According to a 2024 SEC filing, Hinge's programs reduced the hours patients required from human care teams by 95% versus traditional physical therapy.

In the most recent quarter, revenue grew 53% and free cash flow margin nearly doubled to 53% from 27% a year earlier. Hinge reported 2,560 organizational clients, including corporations and government entities.

The consensus price target of just under $60 implies roughly 32% upside. Price targets updated after the company's Nov. 4 earnings report are even more bullish, averaging about $67 and implying roughly 47% upside.

Watchlist Addition: Hinge Health

Overall, 2025 favored KRMN, CRCL, and HNGE, with Hinge Health standing out. Its revenue is growing rapidly and free cash flow improved substantially last quarter.

Hinge's product addresses a major consumer pain point in the U.S. — high healthcare costs — and it wouldn't be surprising to see the stock perform well in 2026 if the company can sustain growth and margins. Investors should watch Hinge to see whether it can maintain its recent momentum.

Thank you for subscribing to The Early Bird, MarketBeat's 7:00 AM newsletter that covers stories that will impact the stock market each day.

This email message is a paid advertisement sent on behalf of Chaikin Analytics, a third-party advertiser of The Early Bird and MarketBeat.

This ad is sent on behalf of Chaikin Analytics, 201 King Of Prussia Rd., Suite 650, Radnor, PA 19087. If you would like to optout from receiving offers from Chaikin Analytics please click here.

If you have questions about your subscription, feel free to email MarketBeat's South Dakota based support team at contact@marketbeat.com.

If you no longer wish to receive email from The Early Bird, you can unsubscribe.

© 2006-2026 MarketBeat Media, LLC. All rights protected.
345 N Reid Pl., Suite 620, Sioux Falls, S.D. 57103-7078. United States of America..

From Our Partners: The AI Arms Race Has a New Contender: VWAV (From Equiscreen)